# Hangzhou Kangsheng Health Consulting Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/hangzhou-kangsheng-health-consulting-co

- Industry: Healthcare IT
- Headquarters: Hangzhou, China
- Website: www.zyhealth.com
- Total disclosed funding: $156M
- Latest round: Series D (Jan 8, 2020)
- Investors on record: 17

## About

Established in 2014 and headquartered in Hangzhou, China, Hangzhou Kangsheng Health Consulting Co., Ltd. operates as a healthcare company that develops and provides diabetes tracking mobile applications and related hardware. In November 2015, it served more than 1 million diabetes patients. In 2016, it started the SaaS business. In 2018, it cooperated with nearly 100 hospitals. As of 2022, it completed eight rounds of financing. It has partnerships with Abbott, Ali Health, and Taobao.

The company's products can be categorized into ClouDr for Pharmacies, ClouDr for Hospital, ClouDr App, and Dr. ClouDr. The ClouDr is a chronic disease management SaaS system, which has connected to 29 provinces and served nearly 2500 hospitals. It supports patients to consult through graphics and videos. The doctors and nurses can retrieve the historical data of patients in the system in real-time.

## Funding rounds

- Series D, Jan 8, 2020 — LB Investment, SIG Asia Investment, Oriental Patron, CMB International Asset Management, Bojiang Capital Management Group, Tasly Holding Group
- Series C, Jan 7, 2020, $7.2M — SIG Asia Investment, Ping An Trust, Samsung Venture Investment, Oriental Patron, Zhongdian Shurong Investment Management
- Series C, Jan 7, 2019, $100M — IDG Capital, LB Investment, China International Capital Corporation, Ping An Trust, Samsung Venture Investment, CEC Data, Meinian Onehealth Healthcare Holdings, Tasly Holding Group
- Series B, Mar 19, 2018, $16M — Tianyi Investment Group
- Series B, Jan 10, 2016, $15M — IDG Capital, Ping An Trust, CoStone Capital, MPC
- Series A, Oct 12, 2015, $15M — IDG Capital, Ping An Trust, MPC
- Angel, Apr 27, 2015, $3M — Matrix Partners, Ping An Trust

## Investors

- Matrix Partners (https://capitalatlas.ai/funds/matrix-partners) — Angel
- Ping An Trust — Angel, Series A, Series B, Series C
- IDG Capital (https://capitalatlas.ai/funds/idg-capital) — Series A, Series B, Series C
- MPC — Series A, Series B
- CoStone Capital (https://capitalatlas.ai/funds/costone-capital) — Series B
- Tianyi Investment Group (https://capitalatlas.ai/funds/tianyi-investment-group) — Series B
- LB Investment (https://capitalatlas.ai/funds/lb-investment) — Series C, Series D
- China International Capital Corporation (https://capitalatlas.ai/funds/china-international-capital-corporation) — Series C
- Samsung Venture Investment (https://capitalatlas.ai/funds/samsung-venture-investment) — Series C
- CEC Data — Series C
- Meinian Onehealth Healthcare Holdings — Series C
- Tasly Holding Group — Series C, Series D
- SIG Asia Investment (https://capitalatlas.ai/funds/sig-asia-investment) — Series C, Series D
- Oriental Patron (https://capitalatlas.ai/funds/oriental-patron) — Series C, Series D
- Zhongdian Shurong Investment Management (https://capitalatlas.ai/funds/zhongdian-shurong-investment-management) — Series C
- CMB International Asset Management (https://capitalatlas.ai/funds/cmb-international-asset-management) — Series D
- Bojiang Capital Management Group (https://capitalatlas.ai/funds/bojiang-capital-management-group) — Series D